223 related articles for article (PubMed ID: 9605518)
1. Expression of a fusion gene consisting of the mouse growth hormone-releasing hormone gene promoter linked to the SV40 T-antigen gene in transgenic mice.
Nogues N; Magnan E; De Grandis P; Butz M; Kineman RD; Kopchick JJ; Frohman LA
Mol Cell Endocrinol; 1998 Feb; 137(2):161-8. PubMed ID: 9605518
[TBL] [Abstract][Full Text] [Related]
2. Placenta-specific expression of the rat growth hormone-releasing hormone gene promoter in transgenic mice.
Nogués N; Del Río JA; Pérez-Riba M; Soriano E; Flavell RA; Boronat A
Endocrinology; 1997 Aug; 138(8):3222-7. PubMed ID: 9231771
[TBL] [Abstract][Full Text] [Related]
3. Development of neuroepithelial tumors of the adrenal medulla in transgenic mice expressing a mouse hypothalamic growth hormone-releasing hormone promoter-simian virus-40 T-antigen fusion gene.
Pecori Giraldi F; Mizobuchi M; Horowitz ZD; Downs TR; Aleppo G; Kier A; Wagner T; Yun JS; Kopchick JJ; Frohman LA
Endocrinology; 1994 Mar; 134(3):1219-24. PubMed ID: 8119162
[TBL] [Abstract][Full Text] [Related]
4. Region- and age-specific differences in proglucagon gene expression in the central nervous system of wild-type and glucagon-simian virus-40 T-antigen transgenic mice.
Lee YC; Campos RV; Drucker DJ
Endocrinology; 1993 Jul; 133(1):171-7. PubMed ID: 8319563
[TBL] [Abstract][Full Text] [Related]
5. Presence of a spermatogenic-specific promoter in the rat growth hormone-releasing hormone gene.
Srivastava CH; Monts BS; Rothrock JK; Peredo MJ; Pescovitz OH
Endocrinology; 1995 Apr; 136(4):1502-8. PubMed ID: 7895659
[TBL] [Abstract][Full Text] [Related]
6. Targeted pituitary tumorigenesis using the human thyrotropin beta-subunit chain promoter in transgenic mice.
Maki K; Miyoshi I; Kon Y; Yamashita T; Sasaki N; Aoyama S; Takahashi E; Namioka S; Hayashizaki Y; Kasai N
Mol Cell Endocrinol; 1994 Nov; 105(2):147-54. PubMed ID: 7859921
[TBL] [Abstract][Full Text] [Related]
7. Targeted expression of SV40 large tumour antigen (TAg) induces a transient enhancement of spermatocyte proliferation and apoptosis.
Tascou S; Nayernia K; Meinhardt A; Schweyer S; Engel W; Trappe R; Burfeind P
Mol Hum Reprod; 2001 Dec; 7(12):1123-31. PubMed ID: 11719589
[TBL] [Abstract][Full Text] [Related]
8. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
[TBL] [Abstract][Full Text] [Related]
9. Tissue specificity of L-pyruvate kinase transgenes results from the combinatorial effect of proximal promoter and distal activator regions.
Miquerol L; Cluzeaud F; Porteu A; Alexandre Y; Vandewalle A; Kahn A
Gene Expr; 1996; 5(6):315-30. PubMed ID: 8836739
[TBL] [Abstract][Full Text] [Related]
10. Autofeedback suppression of growth hormone (GH) secretion in transgenic mice expressing a human GH reporter targeted by tyrosine hydroxylase 5'-flanking sequences to the hypothalamus.
Szabo M; Butz MR; Banerjee SA; Chikaraishi DM; Frohman LA
Endocrinology; 1995 Sep; 136(9):4044-8. PubMed ID: 7649113
[TBL] [Abstract][Full Text] [Related]
11. The gonadotropin-releasing hormone receptor gene promoter directs pituitary-specific oncogene expression in transgenic mice.
Albarracin CT; Frosch MP; Chin WW
Endocrinology; 1999 May; 140(5):2415-21. PubMed ID: 10218996
[TBL] [Abstract][Full Text] [Related]
12. Development of a transgenic mouse that overexpresses a novel product of the growth hormone-releasing hormone gene.
Fang S; Steinmetz R; Walker King D; Zeng P; Vogelweid C; Cooper S; Hangcoc G; Broxmeyer HE; Pescovitz OH
Endocrinology; 2000 Apr; 141(4):1377-83. PubMed ID: 10746641
[TBL] [Abstract][Full Text] [Related]
13. Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice.
Ye X; McCarrick J; Jewett L; Knowles BB
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3916-20. PubMed ID: 8171012
[TBL] [Abstract][Full Text] [Related]
14. Haploid male germ cells show no susceptibility to transformation by simian virus 40 large tumour antigen in transgenic mice.
Nayernia K; Samani AA; Klaproth S; Engel W
Cell Biol Int; 1998; 22(6):437-43. PubMed ID: 10328852
[TBL] [Abstract][Full Text] [Related]
15. Expression of the rat growth hormone-releasing hormone gene in placenta is directed by an alternative promoter.
González-Crespo S; Boronat A
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8749-53. PubMed ID: 1924334
[TBL] [Abstract][Full Text] [Related]
16. Characterization of gastric adenocarcinoma cell lines established from CEA424/SV40 T antigen-transgenic mice with or without a human CEA transgene.
Nöckel J; van den Engel NK; Winter H; Hatz RA; Zimmermann W; Kammerer R
BMC Cancer; 2006 Mar; 6():57. PubMed ID: 16536871
[TBL] [Abstract][Full Text] [Related]
17. High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion gene.
Mikola M; Kero J; Nilson JH; Keri RA; Poutanen M; Huhtaniemi I
Oncogene; 2003 May; 22(21):3269-78. PubMed ID: 12761497
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific expression of kallikrein family transgenes in mice and rats.
Smith MS; Lechago J; Wines DR; MacDonald RJ; Hammer RE
DNA Cell Biol; 1992 Jun; 11(5):345-58. PubMed ID: 1605858
[TBL] [Abstract][Full Text] [Related]
19. Lactation-induced WAP-SV40 Tag transgene expression in C57BL/6J mice leads to mammary carcinoma.
Hüsler MR; Kotopoulis KA; Sundberg JP; Tennent BJ; Kunig SV; Knowles BB
Transgenic Res; 1998 Jul; 7(4):253-63. PubMed ID: 9859214
[TBL] [Abstract][Full Text] [Related]
20. Adrenocortical tumorigenesis in transgenic mice expressing the inhibin alpha-subunit promoter/simian virus 40 T-antigen transgene: relationship between ectopic expression of luteinizing hormone receptor and transcription factor GATA-4.
Rahman NA; Kiiveri S; Rivero-Müller A; Levallet J; Vierre S; Kero J; Wilson DB; Heikinheimo M; Huhtaniemi I
Mol Endocrinol; 2004 Oct; 18(10):2553-69. PubMed ID: 15256532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
